ArticleArthroplasty today2026
High-Volume Hospitals Are Associated With Lower Rates of Mortality Following Revision Arthroplasty for Periprosthetic Joint Infection.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The relationship between hospital case volume and postoperative morbidity following revision arthroplasty for periprosthetic joint infection (PJI) has not been defined. As such, we sought to compare 90-day postoperative mortality rates among patients undergoing antibiotic spacer placement for PJI of the hip or knee between high- vs low-volume hospitals. Materials and methods: The Premier Healthcare Database was queried from 2016 to 2023 for adult patients undergoing antibiotic spacer placement for PJI. Using the Metropolis-Hastings algorithm, a single hospital volume threshold, below which mortality increased, was identified. Patients were divided by those operated on by high- vs low-volume hospitals. Multivariable logistic regression was conducted to assess odds of 90-day mortality and sepsis. Results: In a cohort of 55,670 PJIs, postoperative mortality was decreased in patients who were operated on by hospitals performing ≥35 antibiotic spacers annually (high volume). The adjusted odds of mortality (adjusted odds ratio = 0.76; 95% confidence interval = 0.65-0.88, Conclusions: Patients receiving PJI care at hospitals performing greater than 35 antibiotic spacers annually died less frequently and had improved outcomes than those presenting to lower volume centers. These findings reinforce emerging evidence in support of centralized PJI care centers to improve patient survival.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.